Observational Study
Copyright ©The Author(s) 2019.
World J Hepatol. Apr 27, 2019; 11(4): 391-401
Published online Apr 27, 2019. doi: 10.4254/wjh.v11.i4.391
Table 1 Characteristics of 83 patients with hidradenitis suppurative, Nonalcoholic fatty liver and Nonalcoholic steatohepatitis and intercalsses charactersitics
HS onlyNAFLDP valueNASHP valueNAFLP value
n51321220
Age, mean(SD)43.04 (8.9)41.32 (9.0)0.56441.58 (7.4)0.60240.55 (10.3)0.315
Age cat (%)0.6460.4630.629
< 303 (5.9)4 (12.5)1 (8.3)3 (15.0)
30-3916 (31.4)8 (25.0)2 (16.7)6 (30)
40-4918 (35.3)14 (43.8)7 (58.3)7 (35.0)
> 5014 (27.5)6 (18.8)2 (16.7)4 (20.0)
Male, n (%)17 (33.3)14 (43.8)0.6235 (41.7)0.8359 (45.0)0.52
Diabetes, n (%)12 (23.5)9 (28.1)0.8533 (25.0)0.7646 (30.0)0.794
BMI, mean(SD)28.31 (2.5)27.56 (1.9)0.38127.58 (2.7)0.37627.55 (1.7)0.218
bmi_cat (%)0.5590.5150.384
Normal Weight4 (7.8)4 (12.5)2 (16.7)2 (10.0)
Overweight38 (74.5)26 (81.3)9 (75.0)17 (85.0)
Obese9 (17.6)2 (6.3)1 (8.3)1 (5.0)
IHS4, mean(SD)9.57 (3.6)11.32 (2.8)0.02512.67 (3.6)0.0099.40 (3.9).0.861
IHS4 cat (%)0.0280.0070.97
Mild5 (9.8)3 (9.4)1 (8.3)2 (10.0)
Moderate24 (47.1)10 (31.3)0 (0)10 (50.0)
Severe22 (43.1)19 (59.4)11 (91.7)8 (40)
Hurley (%)0.4940.1970.785
15 (9.8)3 (9.4)1 (8.3)2 (10.0)
224 (47.1)6 (18.8)1 (8.3)5 (25.0)
322 (43.1)23 (71.9)10 (83.3)13 (65.0)
Elevated_liver_enzymes, n (%)19 (37.3)9 (28.1)0.6174 (33.3)0.9985 (25.0)0.482
ADDI_score, mean(SD)2.55 (1.4)3.72 (1.8)< 0.0015.33 (2.2)< 0.0012.75 (1.6)0.603
Inflammatory comorbidities, n (%)2 (3.9)12 (37.5)< 0.0017 (58.3)< 0.0015 (25.0)0.025
In detail (%)0.001< 0.0010.047
Acne conglobata1 (2.0)0 (0)0 (0)0 (0)
Crohn disease0 (0)2 (6.3)1 (8.3)1 (5.0)
Lichen sclerosus1 (2.0)0 (0)0 (0)0 (0)
PASH0 (0)5 (15.6)4 (33.3)1 (5.0)
Psoriasis0 (0)2 (6.3)1 (8.3)1 (5.0)
Spondyloarthritis0 (0)2 (6.3)1 (8.3)1 (5.0)
Uveitis0 (0)1 (3.1)0 (0)1 (5.0)
Positive ultrasound, n (%)11 (21.6)32 (100.0)< 0.00112 (100.0)< 0.00120 (100.0)< 0.001
NASH0 (0)12 (37.5)< 0.00112 (100.0)0 (0)
NAFL0 (0)20 (62.5)< 0.0010 (0)20 (100.0)
Table 2 Differences among hidradenitis suppurativa patients with and without diabetes
Non diabetesDiabetesP value
n6221
Age, mean(SD)42.44 (9.4)41.62 (8.2)0.722
Age cat (%)0.203
< 304 ( 6.5)3 (14.3)
> 5017 (27.4)3 (14.3)
30-3920 (32.3)4 (19.0)
40-4921 (33.9)11 (52.4)
Male, n (%)21 (33.9)10 ( 47.6)0.387
Diabetes, n (%)0 ( 0.0)21 (100.0)<0.001
BMI, mean(SD)28.10 (2.6)27.81 (1.4)0.636
bmi_cat (%)0.161
Normal Weight8 (12.9)0 ( 0.0)
Obese9 (14.5)2 ( 9.5)
Overweight45 (72.6)19 ( 90.5)
IHS4, mean(SD)10.37 (3.6)8.81 (4.1)0.101
IHS4 cat, n (%)0.051
Mild4 ( 6.5)4 ( 19.0)
Moderate23 (37.1)11 ( 52.4)
Severe35 (56.5)6 ( 28.6)
Hurley, n (%)0.022
14 ( 6.5)4 ( 19.0)
214 (22.6)9 ( 42.9)
344 (71.0)8 ( 38.1)
Elevated_liver_enzymes, n (%)21 (33.9)7 ( 33.3)1
ADDI_score, mean(SD)3.13 (1.8)2.62 (2.0)0.275
Inflammatory comorbidities, n (%)9 (14.5)5 ( 23.8)0.518
In.detail, n (%)0.563
53 (85.5)16 ( 76.2)
Acne conglobata1 ( 1.6)0 ( 0.0)
Crohn1 ( 1.6)1 ( 4.8)
Lichen sclerosus0 ( 0.0)1 ( 4.8)
PASH4 ( 6.5)1 ( 4.8)
Psoriasis1 ( 1.6)1 ( 4.8)
Spondyloarthritis1 ( 1.6)1 ( 4.8)
Uveitis1 ( 1.6)0 ( 0.0)
Positive_ultrasound, n (%)31 (50.0)12 ( 57.1)0.754
NASH, n (%)9 (14.5)3 ( 14.3)1
NAFL, n (%)14 (22.6)6 ( 28.6)0.795
Disease, n (%)0.853
HS only39 (62.9)12 ( 57.1)
NAFL14 (22.6)6 ( 28.6)
NASH9 (14.5)3 ( 14.3)